Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Aptose Biosciences Inc. logo

Aptose Biosciences Inc.

Sector: Healthcare   

Industry: Biotechnology

2.50
 
USD
  
-0.22
  
(-8.09%)
Optionable: Yes  Market Cap: 19 M  90-day average vol: 38,787

Previous close: 2.72  Open: 2.73  Bid: 2.5  Ask: 2.71
52 week range    
2.50   
   11.85
Peers   
ADXS / 
INFI / 
CRBP / 
Last updated: Wednesday 4th October 2023
33
MarketXLS Rank
60
Value
15
Technical
26
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

APTO Income Statement

Annual
Invalid dateMay-14Dec-14Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Basic EPS from continuing operations-22.32-0.58-0.52-0.86-0.52-0.67-0.73-0.45
Basic EPS total-22.32-0.58-0.52-0.86-0.52-0.67-0.73-0.45
Basic weighted shares outstanding434666.012 M22 M33 M50 M82 M89 M92267.0
Depreciation50000.053000.0122000.0135000.0138000.0
Depreciation unreconciled50000.053000.0122000.0135000.0138000.0
DepreciationAndAmortization50000.053000.0122000.0135000.0138000.0
Diluted EPS total-22.32-0.58-0.52-0.86-0.52-0.67-0.73-0.45
Diluted normalized net income/share-22.32-0.58-0.52-0.86-0.52-0.67-0.73-0.45
Diluted weighted shares outstanding434666.012 M22 M33 M50 M82 M89 M92267.0
GainOnSaleOfSecurity115000.0-44000.06000.08000.0-1000.0
GeneralAndAdministrativeExpense6 M10 M10 M26 M19 M15 M
Income before tax-12 M-29 M-26 M-55 M-65 M-42 M
Interest income68000.0283000.0574000.0522000.094000.0788000.0
Net income from total operations-12 M-29 M-26 M-55 M-65 M-42 M
NetIncomeCommonStockholders-12 M-29 M-26 M-55 M-65 M-42 M
NetIncomeContinuousOperations-12 M-29 M-26 M-55 M-65 M-42 M
NetNonOperatingInterestIncomeExpense-68000.0-283000.0-574000.0-522000.0-94000.0788000.0
Normalized income-9 M-21 M-19 M-41 M-48 M-31 M
Operating income-12 M-29 M-27 M-56 M-65 M-43 M
Operating income before depreciation (EBITDA)-12 M-29 M-26 M-55 M-65 M-41 M
OperatingExpense12 M29 M27 M56 M65 M43 M
Other income net115000.0-44000.06000.08000.0-1000.0
OtherGandA6 M10 M10 M26 M19 M15 M
Research & development expense6 M19 M17 M29 M46 M28 M
ResearchExpense28 M
SalariesAndWages602000.03 M2 M18 M9 M
Selling Gen & administrative expense6 M10 M10 M26 M19 M15 M
Total Income available for interest expense (EBIT)-12 M-29 M-26 M-55 M-65 M-42 M
Total common shares outstanding27 M38 M74 M89 M89 M92 M
Total net income-12 M-29 M-26 M-55 M-65 M-42 M
Total ordinary shares7 M7 M7 M7 M7 M7 M
TotalExpenses-12 M-29 M-27 M-56 M-65 M43 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and Templates.
Get started today